Joshua D. Ooi

monash university

H指数:37

被引数:4,035

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tregs transduced with a Ro60-reactive TCR have increased immunosuppressive functions in Sjögren’s disease

Ro60反应性TCR转导的Treg在舍格伦综合征中具有增强的免疫抑制功能

iScience

IF4.1

2026-09-280

OAAI

Assessment of pH-Responsive Ionisable Lipid Nanoparticles as Cisplatin Delivery Vehicles for Treating Cisplatin-Resistant Ovarian Cancer

pH响应性可电离脂质纳米颗粒作为顺铂递送载体治疗顺铂耐药性卵巢癌的评估

Pharmaceutics

IF5.5

2026-05-180

TCR recognition of peptide–HLA class II complexes in autoimmunity: Structural insights for therapeutic targeting

TCR对肽-HLA II类复合物的自身免疫识别：治疗靶向的结构见解

Journal of Autoimmunity

IF7

2026-03-230

OAAI

Are All Cells Created Equal? Novel Cell-Based Regenerative Therapies in Inflammatory Bowel Disease

所有细胞都是均一的吗？炎症性肠病的新型基于细胞的再生疗法

International Journal of Molecular Sciences

IF4.9

2026-02-260

OAAI

Hybrid CARs: Rewiring Macrophage Signalling for Targeted Therapy in Acute and Chronic Kidney Inflammation

杂交CARs：重编程巨噬细胞信号以用于急性与慢性肾脏炎症的靶向治疗

Kidney International

IF12.6

2026-02-120

PRE

Characteristics of T-Cells Expressing IL-37 and Its Receptors in Inflammatory Bowel Disease

炎症性肠病中T细胞表达IL-37及其受体的特征

International Journal of Molecular Sciences

IF4.9

2026-02-050

OAAI

Editorial: Community series: systemic vasculitis: advances in pathogenesis and therapies; volume II

编辑：社区系列：系统性血管炎：发病机制和治疗进展；第二卷

Frontiers in Immunology

IF5.9

2026-01-070

OAAI

The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis

β-Synuclein特异性调节性T细胞疗法治疗进展性多发性硬化的潜力

International Journal of Molecular Sciences 2025, Vol. 26, Page 11534

IF4.9

2025-11-280

OAAI

Regulatory T cell therapy for myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis

髓过氧化物酶特异性抗中性粒细胞胞浆抗体相关性血管炎的调节性T细胞疗法

Frontiers in Immunology

IF5.9

2025-11-030

OAAI

Low dose IL-2 administration prevents but fails to treat experimental autoimmune anti-myeloperoxidase glomerulonephritis

低剂量IL-2给药可预防但无法治疗实验性自身免疫性抗髓过氧化物酶肾小球肾炎

Nephrology Dialysis Transplantation

IF5.6

2025-09-010

OAAI

Regulatory T cell therapy for Sjögren's Disease: From pathogenesis to targeted treatment

调节性T细胞疗法治疗舍格伦综合征：从发病机制到靶向治疗

Journal of Translational Autoimmunity

IF3.6

2025-08-260

OAAI

Cryptic but critical: non-canonical antigens in cancer immunotherapy

隐匿但关键：癌症免疫疗法中的非经典抗原

Trends in Immunology

IF13.9

2025-06-180

PRE

High prevalence of HLA DRB1*01:03 in Australian Inflammatory Bowel Disease patients without prediction of refractory disease

JOURNAL OF CROHNS & COLITIS

IF8.7

2025-01-220

PRE

Engineered antigen-specific T regulatory cells suppress autoreactivity to the anti-glomerular basement membrane disease antigen

工程化抗原特异性T调节细胞可抑制对抗肾小球基底膜疾病抗原的自身反应性。

KIDNEY INTERNATIONAL

IF12.6

2025-01-010

OAAI

Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study

CLINICAL KIDNEY JOURNAL

IF4.6

2024-09-060

OAAI

Editorial: Innate immunity in vasculitis

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-06-030

OAAI

Clinical features and prognosis of ANCA-associated vasculitis patients who were double-seropositive for myeloperoxidase-ANCA and proteinase 3-ANCA

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2024-04-021

OAAI

The Influence of Cross-Reactive T Cells in COVID-19

交叉反应性T细胞对新型冠状病毒肺炎的影响

BIOMEDICINES

IF3.9

2024-03-024

OAAI

Smith-specific regulatory T cells halt the progression of lupus nephritis

NATURE COMMUNICATIONS

IF15.7

2024-02-068

OAAI

Epithelially Restricted Interferon Epsilon Protects Against Colitis

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY

IF7.4

2024-01-013

OAAI

Joshua D. Ooi

个人简介

教育背景

工作经历

荣誉奖项

研究方向